PCVX
Vaxcyte Inc
$115.5
Earnings Summary
Revenue | $0Mn |
Net Profits | $-128.7Mn |
Net Profit Margins | -Inf% |
Highlights
Vaxcyte Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2024. On a quarterly growth basis, Vaxcyte Inc has generated NaN% jump in its revenue since last 3-months.
Vaxcyte Inc’s net profit fell -88.33% since last year same period to $-128.7Mn in the Q2 2024. On a quarterly growth basis, Vaxcyte Inc has generated -35.45% fall in its net profits since last 3-months.
Vaxcyte Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2024. On a quarterly growth basis, Vaxcyte Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vaxcyte Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.14 |
EPS Estimate Current Year | -1.14 |
Highlights
Vaxcyte Inc’s earning per share (EPS) estimates for the current quarter stand at -1.14 - a -16.33% fall from last quarter’s estimates.
Vaxcyte Inc’s earning per share (EPS) estimates for the current year stand at -1.14.
Key Ratios
Key ratios of the Vaxcyte Inc post its Q2 2024 earnings
Earning Per Share (EPS) | -1.1 |
Highlights
Vaxcyte Inc’s earning per share (EPS) fell -57.14% since last year same period to -1.1 in the Q2 2024. This indicates that the Vaxcyte Inc has generated -57.14% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-06 | -0.98 | -1.1 | -12.24% |
2024-05-08 | -1.17 | -0.85 | 27.35% |
₹0 US Stocks a/c Opening Fee